Nchi: Kanada
Lugha: Kiingereza
Chanzo: Health Canada
PILOCARPINE HYDROCHLORIDE
METHAPHARM INC
N07AX01
PILOCARPINE
5MG
TABLET
PILOCARPINE HYDROCHLORIDE 5MG
ORAL
100
Prescription
PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS
Active ingredient group (AIG) number: 0107358009; AHFS:
APPROVED
2020-10-14
_PILOCARPINE HYDROCHLORIDE TABLETS Product Monograph _ _Page 1 of 33 _ PRODUCT MONOGRAPH PR PILOCARPINE HYDROCHLORIDE TABLETS 5 MG CHOLINOMIMETIC AGENT Methapharm Inc 81 Sinclair Boulevard Brantford, Ontario N3S 7X6, Canada Date of Revision: October 13, 2020 Submission Control No.: 241563 _PILOCARPINE HYDROCHLORIDE TABLETS Product Monograph _ _Page 2 of 33 _ Table of Contents PART I: HEALTH PROFESSIONAL INFORMATION ..........................................................3 SUMMARY PRODUCT INFORMATION ........................................................................3 INDICATIONS AND CLINICAL USE ..............................................................................3 CONTRAINDICATIONS ...................................................................................................4 WARNINGS AND PRECAUTIONS ..................................................................................4 ADVERSE REACTIONS ....................................................................................................6 DRUG INTERACTIONS ..................................................................................................11 DOSAGE AND ADMINISTRATION ..............................................................................11 OVERDOSAGE ................................................................................................................12 ACTION AND CLINICAL PHARMACOLOGY ............................................................13 STORAGE AND STABILITY ..........................................................................................18 DOSAGE FORMS, COMPOSITION AND PACKAGING .............................................18 PART II: SCIENTIFIC INFORMATION ...............................................................................19 PHARMACEUTICAL INFORMATION ..........................................................................19 CLINICAL TRIALS ..........................................................................................................20 DETAILED PHARMAC Soma hati kamili